(Q42908270)

10 November 2017

title

Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials (English)

1 reference

aneurysmal subarachnoid hemorrhage

10 November 2017

main subject

1 reference

2

Randall T Higashida

1 reference

10 November 2017

R Loch Macdonald

1

1 reference

10 November 2017

Emanuela Keller

3

1 reference

10 November 2017

Stephan A Mayer

4

1 reference

10 November 2017

Andy Molyneux

5

1 reference

10 November 2017

Andreas Raabe

6

1 reference

10 November 2017

Peter Vajkoczy

7

1 reference

10 November 2017

Isabel Wanke

8

1 reference

10 November 2017

Aline Frey

9

1 reference

10 November 2017

Angelina Marr

10

1 reference

10 November 2017

Sébastien Roux

11

1 reference

10 November 2017

Neal F Kassell

12

1 reference

10 November 2017

publication date

1 December 2010

1 reference

10 November 2017

1 reference

10 November 2017

volume

13

1 reference

10 November 2017

issue

3

1 reference

10 November 2017

page(s)

416-424

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-010-9433-3

10 November 2017

exact match

0 references

cites work

Cerebral Vasospasm and Ruptured Intracranial Aneurysm

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9433-3

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9433-3

Prediction of function after stroke: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9433-3

Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9433-3

Variability in modified Rankin scoring across a large cohort of international observers.

21 January 2018

1 reference

12 December 2020

Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu

1 reference

12 December 2020

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

The impact of aneurysmal subarachnoid hemorrhage on functional outcome

1 reference

12 December 2020

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

1 reference

12 December 2020

Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis.

1 reference

12 December 2020

Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Emotional and cognitive consequences of head injury in relation to the glasgow outcome scale

1 reference

12 December 2020

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

12 December 2020

New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage

1 reference

12 December 2020

Effect of endothelin-receptor antagonists on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage remains unclear

1 reference

12 December 2020

Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage.

1 reference

12 December 2020

Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.

1 reference

12 December 2020

Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

1 reference

12 December 2020

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

1 reference

12 December 2020

Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage.

1 reference

12 December 2020

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

1 reference

12 December 2020

Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome

1 reference

12 December 2020

Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

1 reference

12 December 2020

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

12 December 2020

Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study

1 reference

12 December 2020

Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study

1 reference

12 December 2020

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

1 reference

12 December 2020

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

1 reference

12 December 2020

Calcium antagonists for aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

10.1007/S12028-010-9433-3

Identifiers

DOI

1 reference

10 November 2017

1 reference